Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT00113516 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00113516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00113516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
March 31, 2009
Enrollment
84 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer